Spore.Bio Secures $23M Series A Funding in Microbiology Innovation

Spore.Bio has successfully raised $23 million in a Series A funding round led by the private equity firm Localglobe. The company's pioneering microbiology testing technology, which utilizes light to deliver rapid results within minutes, is set to transform safety protocols across various industries. The technology shown by Spore.Bio has demonstrated accuracy comparable to traditional methods and has established a strategic partnership with the Pasteur Institute, a leading microbiology authority. Additionally, the company has acquired a local competitor, expanding its reach to over 200 factories poised to implement this innovative technology. Localglobe commends the founders Amine Raji, Maxime Mistretta, and Mohamed Tazi, along with their multidisciplinary team, for driving advances in food safety and public health on a global scale. The introduction of key individuals, Raffi, Maud, and the Singular team, signifies further growth momentum for the venture. This development is a significant achievement for European industry and France's microbiology expertise.